Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Asset Utilization Ratio came in at 0.98 in Q1 2026, down 5.54% YoY from 1.04 in Q1 2025, and little changed on a QoQ basis from 0.98 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Asset Utilization Ratio data on file, last reported at 0.98 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 5.54% year-over-year to 0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.98 (down 5.54% YoY) and the FY2025 annual result came in at 1.74, up 94.64% from the prior year.
- Asset Utilization Ratio held at 0.98 in Q1 2026, from 0.98 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.33 in Q3 2025 to a low of 0.34 in Q1 2022.
- A 5-year average of 0.76 and a median of 0.72 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 225.55% — and 2026, when it declined 5.54%.
- Tracing BCRX's Asset Utilization Ratio over 5 years: stood at 0.49 in 2022, then jumped by 30.46% to 0.64 in 2023, then soared by 44.06% to 0.92 in 2024, then gained by 6.34% to 0.98 in 2025, then rose by 0.37% to 0.98 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.98 (Q1 2026), 0.98 (Q4 2025), and 1.33 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 1.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 |
| Mar 31, 2026 | 0.98 |
| Dec 31, 2025 | 0.98 |
| Sep 30, 2025 | 1.33 |
| Jun 30, 2025 | 1.19 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 0.92 |
| Sep 30, 2024 | 0.86 |
| Jun 30, 2024 | 0.81 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.64 |
| Sep 30, 2023 | 0.60 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.55 |
| Dec 31, 2022 | 0.49 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.42 |